×
S&P 500   3,902.33 (+0.06%)
DOW   31,518.82 (+0.26%)
QQQ   291.85 (-0.21%)
AAPL   141.42 (-0.17%)
MSFT   262.33 (-0.97%)
META   168.75 (-0.44%)
GOOGL   2,292.71 (-1.03%)
AMZN   111.60 (-1.43%)
TSLA   736.00 (+0.17%)
NVDA   166.61 (-1.23%)
NIO   23.24 (+1.26%)
BABA   119.81 (+0.91%)
AMD   84.23 (-2.24%)
MU   59.94 (+1.97%)
CGC   3.72 (-1.85%)
T   21.01 (+1.11%)
GE   67.46 (+1.12%)
F   12.33 (+2.41%)
DIS   100.16 (+3.67%)
AMC   13.80 (-2.34%)
PFE   51.48 (-0.77%)
PYPL   75.45 (-0.65%)
NFLX   188.18 (-0.51%)
S&P 500   3,902.33 (+0.06%)
DOW   31,518.82 (+0.26%)
QQQ   291.85 (-0.21%)
AAPL   141.42 (-0.17%)
MSFT   262.33 (-0.97%)
META   168.75 (-0.44%)
GOOGL   2,292.71 (-1.03%)
AMZN   111.60 (-1.43%)
TSLA   736.00 (+0.17%)
NVDA   166.61 (-1.23%)
NIO   23.24 (+1.26%)
BABA   119.81 (+0.91%)
AMD   84.23 (-2.24%)
MU   59.94 (+1.97%)
CGC   3.72 (-1.85%)
T   21.01 (+1.11%)
GE   67.46 (+1.12%)
F   12.33 (+2.41%)
DIS   100.16 (+3.67%)
AMC   13.80 (-2.34%)
PFE   51.48 (-0.77%)
PYPL   75.45 (-0.65%)
NFLX   188.18 (-0.51%)
S&P 500   3,902.33 (+0.06%)
DOW   31,518.82 (+0.26%)
QQQ   291.85 (-0.21%)
AAPL   141.42 (-0.17%)
MSFT   262.33 (-0.97%)
META   168.75 (-0.44%)
GOOGL   2,292.71 (-1.03%)
AMZN   111.60 (-1.43%)
TSLA   736.00 (+0.17%)
NVDA   166.61 (-1.23%)
NIO   23.24 (+1.26%)
BABA   119.81 (+0.91%)
AMD   84.23 (-2.24%)
MU   59.94 (+1.97%)
CGC   3.72 (-1.85%)
T   21.01 (+1.11%)
GE   67.46 (+1.12%)
F   12.33 (+2.41%)
DIS   100.16 (+3.67%)
AMC   13.80 (-2.34%)
PFE   51.48 (-0.77%)
PYPL   75.45 (-0.65%)
NFLX   188.18 (-0.51%)
S&P 500   3,902.33 (+0.06%)
DOW   31,518.82 (+0.26%)
QQQ   291.85 (-0.21%)
AAPL   141.42 (-0.17%)
MSFT   262.33 (-0.97%)
META   168.75 (-0.44%)
GOOGL   2,292.71 (-1.03%)
AMZN   111.60 (-1.43%)
TSLA   736.00 (+0.17%)
NVDA   166.61 (-1.23%)
NIO   23.24 (+1.26%)
BABA   119.81 (+0.91%)
AMD   84.23 (-2.24%)
MU   59.94 (+1.97%)
CGC   3.72 (-1.85%)
T   21.01 (+1.11%)
GE   67.46 (+1.12%)
F   12.33 (+2.41%)
DIS   100.16 (+3.67%)
AMC   13.80 (-2.34%)
PFE   51.48 (-0.77%)
PYPL   75.45 (-0.65%)
NFLX   188.18 (-0.51%)
NYSE:IVC

Invacare Stock Forecast, Price & News

$1.59
+0.05 (+3.25%)
(As of 06/28/2022 10:23 AM ET)
Add
Compare
Today's Range
$1.59
$1.64
50-Day Range
$0.83
$1.66
52-Week Range
$0.80
$8.83
Volume
4,634 shs
Average Volume
873,995 shs
Market Capitalization
$56.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.50
30 days | 90 days | 365 days | Advanced Chart

Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

IVC Stock Forecast (MarketRank)

Overall MarketRank

2.44 out of 5 stars

Medical Sector

171st out of 1,436 stocks

Surgical Appliances & Supplies Industry

8th out of 30 stocks

Analyst Opinion: 3.5Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -
Invacare logo

About Invacare (NYSE:IVC)

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.

IVC Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
46120310
Employees
3,000
Year Founded
1885

Company Calendar

Last Earnings
5/09/2022
Today
6/28/2022
Next Earnings (Estimated)
8/03/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$8.50
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+434.6%
Consensus Rating
Buy
Rating Score (0-4)
3
Research Coverage
2 Analysts

Profitability

Net Income
$-45.56 million
Pretax Margin
-5.68%

Debt

Sales & Book Value

Annual Sales
$872.46 million
Cash Flow
$0.94 per share
Book Value
$5.54 per share

Miscellaneous

Free Float
33,188,000
Market Cap
$56.68 million
Optionable
Optionable
Beta
0.85

Social Links















Invacare Frequently Asked Questions

Should I buy or sell Invacare stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Invacare stock.
View analyst ratings for Invacare
or view top-rated stocks.

What is Invacare's stock price forecast for 2022?

2 equities research analysts have issued 12 month price targets for Invacare's shares. Their IVC stock forecasts range from $8.00 to $9.00. On average, they anticipate Invacare's stock price to reach $8.50 in the next year. This suggests a possible upside of 434.6% from the stock's current price.
View analysts' price targets for Invacare
or view top-rated stocks among Wall Street analysts.

How has Invacare's stock price performed in 2022?

Invacare's stock was trading at $2.72 at the beginning of 2022. Since then, IVC shares have decreased by 41.5% and is now trading at $1.59.
View the best growth stocks for 2022 here
.

When is Invacare's next earnings date?

Invacare is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Invacare
.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) posted its quarterly earnings results on Monday, May, 9th. The health services provider reported ($0.69) EPS for the quarter, missing analysts' consensus estimates of ($0.43) by $0.26. The health services provider had revenue of $200.99 million for the quarter, compared to analyst estimates of $196.34 million. Invacare had a negative net margin of 6.35% and a negative trailing twelve-month return on equity of 15.20%.
View Invacare's earnings history
.

Who are Invacare's key executives?

Invacare's management team includes the following people:
  • Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 54, Pay $994.49k)
  • Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 59, Pay $485.86k)
  • Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel, Chief Admin. Officer & Sec. (Age 64, Pay $467.65k) (LinkedIn Profile)
  • Mr. Joost Beltman, Sr. VP & GM of North America (Age 53, Pay $446.31k)
  • Ms. Angela Goodwin, Sr. VP & Chief Information Technology Officer (Age 58, Pay $328.96k)
  • Lois Lee CTP, Director of Treasury, Investor Relations & Corp. Comm.
  • Mr. Rick A. Cassiday, Sr. VP & Chief HR Officer (Age 56)
  • Mr. Geoffrey P. Purtill, Sr. VP and GM of EMEA & APAC (Age 52)

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare CEO Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among Invacare's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Who are Invacare's major shareholders?

Invacare's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (6.54%), Renaissance Technologies LLC (5.47%), Rutabaga Capital Management LLC MA (5.22%), Dimensional Fund Advisors LP (3.90%), Acadian Asset Management LLC (2.63%) and State Street Corp (1.79%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, Kathleen P Leneghan, Matthew E Monaghan and Steven H Rosen.
View institutional ownership trends for Invacare
.

Which major investors are selling Invacare stock?

IVC stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Dimensional Fund Advisors LP, Assenagon Asset Management S.A., Stephens Inc. AR, Shepherd Kaplan Krochuk LLC, Engineers Gate Manager LP, JPMorgan Chase & Co., and Royal Bank of Canada. Company insiders that have sold Invacare company stock in the last two years include Anthony Laplaca, and Baiju R Shah.
View insider buying and selling activity for Invacare
or view top insider-selling stocks.

Which major investors are buying Invacare stock?

IVC stock was purchased by a variety of institutional investors in the last quarter, including Rutabaga Capital Management LLC MA, Acadian Asset Management LLC, Invesco Ltd., Charles Schwab Investment Management Inc., Los Angeles Capital Management LLC, Panagora Asset Management Inc., XTX Topco Ltd, and Paradigm Capital Management Inc. NY. Company insiders that have bought Invacare stock in the last two years include Anthony Laplaca, Kathleen P Leneghan, Matthew E Monaghan, and Steven H Rosen.
View insider buying and selling activity for Invacare
or or view top insider-buying stocks.

How do I buy shares of Invacare?

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invacare's stock price today?

One share of IVC stock can currently be purchased for approximately $1.59.

How much money does Invacare make?

Invacare (NYSE:IVC) has a market capitalization of $56.68 million and generates $872.46 million in revenue each year. The health services provider earns $-45.56 million in net income (profit) each year or ($1.60) on an earnings per share basis.

How many employees does Invacare have?

Invacare employs 3,000 workers across the globe.

When was Invacare founded?

Invacare was founded in 1885.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The official website for Invacare is www.invacare.com. The health services provider can be reached via phone at (440) 329-6000, via email at [email protected], or via fax at 877-619-7996.

This page (NYSE:IVC) was last updated on 6/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.